Surgical Sealants and Adhesives Market by Product Type (Natural Biological Sealants & Adhesives and Semi-Synthetic Sealants & Adhesives), Indication (Tissue Sealing & Hemostasis and Tissue Engineering), and Application (Central Nervous System, General Sur

Surgical Sealants and Adhesives Market by Product Type (Natural Biological Sealants & Adhesives and Semi-Synthetic Sealants & Adhesives), Indication (Tissue Sealing & Hemostasis and Tissue Engineering), and Application (Central Nervous System, General Surgeries, Cardiovascular Surgeries, Cosmetic Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

The surgical sealants & adhesives market was valued at $2699.2XXX million in 2020, and is estimated to reach $5,165.2xxx million by 2030, growing at a CAGR of 6.7XX% from 2021 to 2030. Surgical sealant is a device, which is used during a surgery to avoid prevent surgical complications such as air and fluid leaks. Surgical sealants and & adhesives are available in the form of films and foams, and aidwhich help by creating a hemostatic layer , which that stops the blood and air leakage from the targeted area.

Growth of the global surgical sealants & adhesives market is majorly driven by alarming increase in number of surgeries; , rise in government initiatives for development of pharmaceutical and & medical device industry; , and increase in number of approvals for surgical seleantsealant products. In addition, as per the statistics provided by the American Society of Plastic Surgeons, in 2019, approximately 1.8 million cases of cosmetic minimally- invasive surgeries were performed in the U.S. The rise in demand for surgical procedures and surge increase in the usage of surgical sealants and & adhesives product drives the market growth. Moreover, as per the American Cancer Society Statistics 2021, in the U.S., there were about 44,280 new cases of thyroid cancer, out of which 12,150 were in men and 32,130 in women. Furthermore, as per the Organization for Economic Co-operation and Development, in 2018, there were 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the increasing increase in incidences of emergency surgeries , and extensive surge in uses of surgical sealants & adhesives propels the growth of the market.

Increase in government support for management of Hashimoto’s thyroiditis and surge in demand for effective treatment are the major factors that drive the global surgical sealants & adhesives market. In addition, the key players Baxter International and Integra Life Sciences, which provide numerous surgical sealants & adhesives products contributes toward the market growth. Rise in demand for surgical sealants & adhesives during surgical procedures act a key driving force for expansion of the global market.

Cardiovascular diseases (CVDs) are the leading cause of death globallyacross the globe, and it takes anwith an estimate ofd 17.9 million lives fatalities each year. According to report of the British Heart Foundation, in 2021, 7.6 million people live withwere diagnosed with heart & circulatory diseases, and it causescausing about 25% death in the UK. Cardiovascular diseases are a group of disorders of the heart & blood vessels, and itwhich include coronary heart disease, cerebrovascular disease, and rheumatic heart disease, and other conditions. Thus, rise in use of surgical sealants & adhesives during cardiac surgeries expected to contributes towards the growth of surgical sealants & adhesives market.

However, high cost associated with surgical sealants and the availability of replacements for surgical adhesives and & sealants hinder the growth of this market. For instance, minimally invasive surgeries surgery is a an alternative , as this procedure which only needs a small incision for the operation to be performed, thus eliminating the complications associated with bleeding and air leakage. Conversely, the introduction of novel surgical sealants and & adhesives is expected to create lucrative opportunities for the market.

The global surgical sealants and & adhesives market is segmented based onon the basis of product, indication, application, and region. On the basis ofDepending on the product, the market is bifurcated into natural/biological sealants & adhesives and synthetic /& semisynthetic sealants and & adhesives. Natural/biological sealants and &adhesives are further segmentedclassified into by type and by origin.

By According to type, natural/biological sealants and & adhesives are segmented into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and & adhesives are subsegmented classified into fibrin- based, collagen- based, based, and albumin- based. Polysaccharide-based sealants and & adhesives are further classified into chitosan- based and other polysaccharide- based. By As per origin, natural/biological sealants and & adhesives are divided fragmented into animal based, human based, and plant based. Synthetic and semisynthetic sealants and & adhesives are further segmenteddifferentiated into cyanoacrylates, polyethylene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based onBy indication, it is fragmented differentiated into surgical hemostasis & tissue sealing and tissue engineering. The According to applications application, it is segmented into covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the marketit is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global surgical sealants & adhesives market are Baxter International Inc., B.Braun Melsungen AG, Becton Dickinson & Company, Cryolife Inc., CSL Ltd., Johnson & Johnson, Integra Life Sciences, Occular Therapeutix Inc., Sanofi, and Sealeantis.

KEY BENEFITS FOR STAKEHOLDERS

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global surgical sealants & adhesives market to identify the prevailing opportunities.
This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- & country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENT


By Product:

Natural/Biological Sealants and Adhesives

By Type

Polypeptide/Protein-based Sealants and Adhesives
Fibrin- Basedbased
Collagen -bBased
Gelatin Gelatin-Basedbased
Albumin- Basedbased
Polysaccharide-based Sealants and Adhesives
Chitosan- Basedbased
Other Polysaccharide- Basedbased

By Origin

Human Blood- Basedbased
Animal- Basedbased
Plant- Basedbased
Synthetic and Semisynthetic Sealants and & Adhesives
Cyanoacrylates
Polyethylene Glycol-based Hydrogel
Urethane-based Adhesives
Other Synthetic Sealants and Adhesives

By Indication

Tissue Sealing and & Hemostasis
Tissue Engineering

By Application

Central Nervous System (CNS) Surgeries
General Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Cosmetic Surgeries
Ophthalmic Surgeries
Urological Surgeries
Pulmonary Surgeries
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY MARKET PLAYERS

B.Braun Melsungen AG
Baxter InteranationalInternational Inc.
Becton Dickinson and Company
Cryolife Inc.
CSL Ltd.
Johnson & Johnson
Integra Life Sciences
Occular Therapeutix Inc.
Sanofi
Sealeantis


CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.2.3.Top winning strategies, by year, 2015–2018*
3.2.4.Top winning strategies, by development, 2015–2018* (%)
3.2.5.Top winning strategies, by company, 2015–2018*
3.3.Porter’s five forces analysis
3.4.Porter’s five forces analysis
3.5.Top player positioning, 2016
3.6.Market dynamics
3.6.1.Drivers
3.6.1.1.Increase in ageing population and rise in awareness towards surgical sealants and adhesives
3.6.1.2.Surge in prevalence of chronic diseases and rise in surgical procedures conducted globally
3.6.1.3.Surge in adoption of technologically advanced products
3.6.2.Restraints
3.6.2.1.High cost and extensive clinical data required for the launch of new surgical sealants and adhesives
3.6.2.2.Popularity of minimally invasive surgeries
3.6.3.Opportunity
3.6.3.1.Introduction of novel surgical sealants and adhesives and rise in healthcare spending
CHAPTER 4:SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT
4.1.Overview
4.2.Market size and forecast
4.3.Natural/biological surgical sealants and adhesives
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Natural/biological sealants and adhesives, by type
4.3.3.1.Market size and forecast
4.3.3.2.Polypeptide/protein-based sealants and adhesives
4.3.3.2.1.Market size and forecast
4.3.3.2.2.Fibrin based
4.3.3.2.2.1.Market size and forecast
4.3.3.2.3.Collagen based
4.3.3.2.3.1.Market size and forecast
4.3.3.2.4.Gelatin based
4.3.3.2.4.1.Market size and forecast
4.3.3.2.5.Albumin based
4.3.3.2.5.1.Market size and forecast
4.3.3.3.Polysaccharide-based sealants and adhesives
4.3.3.3.1.Market size and forecast
4.3.3.3.2.Chitosan based
4.3.3.3.2.1.Market size and forecast
4.3.3.3.3.Other polysaccharide based
4.3.3.3.3.1.Market size and forecast
4.3.4.Natural/biological sealants and adhesives, by origin
4.3.4.1.Market size and forecast
4.3.4.2.Human blood based
4.3.4.2.1.Market size and forecast
4.3.4.3.Animal based
4.3.4.3.1.Market size and forecast
4.3.4.4.Plant based
4.3.4.4.1.Market size and forecast
4.4.Synthetic & semisynthetic sealants and adhesives
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Cyanoacrylates
4.4.3.1.Market size and forecast
4.4.4.Polyethylene glycol-based hydrogel
4.4.4.1.Market size and forecast
4.4.5.Urethane-based adhesives
4.4.5.1.Market size and forecast
4.4.6.Other synthetic sealants and adhesives
4.4.6.1.Market size and forecast
CHAPTER 5:SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Central nervous system (CNS) surgeries
5.2.1.Market size and forecast, by region
5.3.General surgeries
5.3.1.Market size and forecast, by region
5.4.Cardiovascular surgeries
5.4.1.Market size and forecast, by region
5.5.Orthopedic surgeries
5.5.1.Market size and forecast, by region
5.6.Cosmetic surgeries
5.6.1.Market size and forecast, by region
5.7.Ophthalmic surgeries
5.7.1.Market size and forecast, by region
5.8.Urological surgeries
5.8.1.Market size and forecast, by region
5.9.Pulmonary surgeries
5.9.1.Market size and forecast, by region
5.10.Others
5.10.1.Market size and forecast, by region
CHAPTER 6:SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Tissue sealing & hemostasis
6.2.1.Market size and forecast, by region
6.3.Tissue engineering
6.3.1.Market size and forecast, by region
CHAPTER 7:SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by product
7.2.3.Market size and forecast, by indication
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by country
7.2.5.1.U.S. market size and forecast
7.2.5.2.Canada market size and forecast
7.2.5.3.Mexico market size and forecast
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by product
7.3.3.Market size and forecast, by indication
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country
7.3.5.1.Germany market size and forecast
7.3.5.2.UK market size and forecast
7.3.5.3.France market size and forecast
7.3.5.4.Italy market size and forecast
7.3.5.5.Spain market size and forecast
7.3.5.6.Rest of Europe market size and forecast
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by product
7.4.3.Market size and forecast, by indication
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by country
7.4.5.1.Japan market size and forecast
7.4.5.2.China market size and forecast
7.4.5.3.India market size and forecast
7.4.5.4.Australia market size and forecast
7.4.5.5.South Korea market size and forecast
7.4.5.6.Rest of Asia-Pacific market size and forecast
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by product
7.5.3.Market size and forecast, by indication
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil market size and forecast
7.5.5.2.South Africa market size and forecast
7.5.5.3.Saudi Arabia market size and forecast
7.5.5.4.Rest of LAMEA market size and forecast
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.2.3.Top winning strategies, by year, 2015–2018*
3.2.4.Top winning strategies, by development, 2015–2018* (%)
3.2.5.Top winning strategies, by company, 2015–2018*
3.3.Porter’s five forces analysis
3.4.Porter’s five forces analysis
3.5.Top player positioning, 2016
3.6.Market dynamics
3.6.1.Drivers
3.6.1.1.Increase in ageing population and rise in awareness towards surgical sealants and adhesives
3.6.1.2.Surge in prevalence of chronic diseases and rise in surgical procedures conducted globally
3.6.1.3.Surge in adoption of technologically advanced products
3.6.2.Restraints
3.6.2.1.High cost and extensive clinical data required for the launch of new surgical sealants and adhesives
3.6.2.2.Popularity of minimally invasive surgeries
3.6.3.Opportunity
3.6.3.1.Introduction of novel surgical sealants and adhesives and rise in healthcare spending
CHAPTER 4:SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT
4.1.Overview
4.2.Market size and forecast
4.3.Natural/biological surgical sealants and adhesives
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Natural/biological sealants and adhesives, by type
4.3.3.1.Market size and forecast
4.3.3.2.Polypeptide/protein-based sealants and adhesives
4.3.3.2.1.Market size and forecast
4.3.3.2.2.Fibrin based
4.3.3.2.2.1.Market size and forecast
4.3.3.2.3.Collagen based
4.3.3.2.3.1.Market size and forecast
4.3.3.2.4.Gelatin based
4.3.3.2.4.1.Market size and forecast
4.3.3.2.5.Albumin based
4.3.3.2.5.1.Market size and forecast
4.3.3.3.Polysaccharide-based sealants and adhesives
4.3.3.3.1.Market size and forecast
4.3.3.3.2.Chitosan based
4.3.3.3.2.1.Market size and forecast
4.3.3.3.3.Other polysaccharide based
4.3.3.3.3.1.Market size and forecast
4.3.4.Natural/biological sealants and adhesives, by origin
4.3.4.1.Market size and forecast
4.3.4.2.Human blood based
4.3.4.2.1.Market size and forecast
4.3.4.3.Animal based
4.3.4.3.1.Market size and forecast
4.3.4.4.Plant based
4.3.4.4.1.Market size and forecast
4.4.Synthetic & semisynthetic sealants and adhesives
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Cyanoacrylates
4.4.3.1.Market size and forecast
4.4.4.Polyethylene glycol-based hydrogel
4.4.4.1.Market size and forecast
4.4.5.Urethane-based adhesives
4.4.5.1.Market size and forecast
4.4.6.Other synthetic sealants and adhesives
4.4.6.1.Market size and forecast
CHAPTER 5:SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Central nervous system (CNS) surgeries
5.2.1.Market size and forecast, by region
5.3.General surgeries
5.3.1.Market size and forecast, by region
5.4.Cardiovascular surgeries
5.4.1.Market size and forecast, by region
5.5.Orthopedic surgeries
5.5.1.Market size and forecast, by region
5.6.Cosmetic surgeries
5.6.1.Market size and forecast, by region
5.7.Ophthalmic surgeries
5.7.1.Market size and forecast, by region
5.8.Urological surgeries
5.8.1.Market size and forecast, by region
5.9.Pulmonary surgeries
5.9.1.Market size and forecast, by region
5.10.Others
5.10.1.Market size and forecast, by region
CHAPTER 6:SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Tissue sealing & hemostasis
6.2.1.Market size and forecast, by region
6.3.Tissue engineering
6.3.1.Market size and forecast, by region
CHAPTER 7:SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by product
7.2.3.Market size and forecast, by indication
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by country
7.2.5.1.U.S. market size and forecast
7.2.5.2.Canada market size and forecast
7.2.5.3.Mexico market size and forecast
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by product
7.3.3.Market size and forecast, by indication
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country
7.3.5.1.Germany market size and forecast
7.3.5.2.UK market size and forecast
7.3.5.3.France market size and forecast
7.3.5.4.Italy market size and forecast
7.3.5.5.Spain market size and forecast
7.3.5.6.Rest of Europe market size and forecast
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by product
7.4.3.Market size and forecast, by indication
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by country
7.4.5.1.Japan market size and forecast
7.4.5.2.China market size and forecast
7.4.5.3.India market size and forecast
7.4.5.4.Australia market size and forecast
7.4.5.5.South Korea market size and forecast
7.4.5.6.Rest of Asia-Pacific market size and forecast
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by product
7.5.3.Market size and forecast, by indication
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil market size and forecast
7.5.5.2.South Africa market size and forecast
7.5.5.3.Saudi Arabia market size and forecast
7.5.5.4.Rest of LAMEA market size and forecast
CHAPTER 8:COMPANY PROFILES
8.1.B. Braun Melsungen AG
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.Baxter International
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.Becton & Dickinson
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.CryoLife, Inc.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.CSL Limited
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.Integra Lifesciences Corporation
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.Johnson & Johnson
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.Ocular Therapeutix Inc.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Product portfolio
8.8.4.Business performance
8.8.5.Key strategic moves and developments
8.9.Sanofi
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.Sealantis Ltd.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
List of Tables
TABLE 01.RECENT SURGICAL SEALANTS & ADHESIVES PRODUCT LAUNCHES AND APPROVALS
TABLE 02.LIFE SCIENCE/HEALTHCARE SPENDING BY COUNTRIES (%), 2016
TABLE 03.GLOBAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 04.GLOBAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 05.NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 06.NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 07.NATURAL/BIOLOGICAL SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2016–2023 ($MILLION)
TABLE 08.NATURAL/BIOLOGICAL SURGICAL SEALANTS AND ADHESIVES, BY TYPE, 2016–2023 (KILOGRAM)
TABLE 09.POLYPEPTIDE/PROTEIN-BASED SEALANTS AND ADHESIVES, BY TYPE, 2016–2023 ($MILLION)
TABLE 10.POLYPEPTIDE/PROTEIN-BASED SEALANTS AND ADHESIVES, BY TYPE, 2016–2023 (KILOGRAM)
TABLE 11.FIBRIN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 12.FIBRIN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 13.COLLAGEN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 14.COLLAGEN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 15.GELATIN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 16.GELATIN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 17.ALBUMIN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 18.ALBUMIN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 19.POLYSACCHARIDE-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 20.POLYSACCHARIDE-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 21.CHITOSAN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 22.CHITOSAN-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 23.OTHER POLYSACCHARIDE-BASED ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 24.OTHER POLYSACCHARIDE-BASED ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 25.NATURAL BIOLOGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 ($MILLION)
TABLE 26.NATURAL BIOLOGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 (KILOGRAM)
TABLE 27.HUMAN BLOOD-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 28.HUMAN BLOOD-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 29.ANIMAL-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 30.ANIMAL-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 31.COMMERCIALLY AVAILABLE PLANT-BASED SURGICAL SEALANTS AND ADHESIVES
TABLE 32.PLANT-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 33.PLANT-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 34.SYNTHETIC AND SEMISYNTHETIC SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 35.SYNTHETIC AND SEMISYNTHETIC SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 36.CYANOACRYLATES SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 37.CYANOACRYLATES SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 38.POLYETHYLENE GLYCOL-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 39.POLYETHYLENE GLYCOL-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 40.URETHANE-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 41.URETHANE-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 42.OTHER SYNTHETIC-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 43.OTHER SYNTHETIC-BASED SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 44.GLOBAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 ($MILLION)
TABLE 45.GLOBAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 (KILOGRAM)
TABLE 46.SURGICAL SEALANTS AND ADHESIVES MARKET FOR CENTRAL NERVOUS SYSTEM (CNS) SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 47.SURGICAL SEALANTS AND ADHESIVES MARKET FOR CENTRAL NERVOUS SYSTEM (CNS) SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 48.SURGICAL SEALANTS AND ADHESIVES MARKET FOR GENERAL SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 49.SURGICAL SEALANTS AND ADHESIVES MARKET FOR GENERAL SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 50.SURGICAL SEALANTS AND ADHESIVES MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 51.SURGICAL SEALANTS AND ADHESIVES MARKET FOR CARDIOVASCULAR SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 52.FIBRIN SEALANTS USED IN ORTHOPEDIC SURGERIES
TABLE 53.SURGICAL SEALANTS AND ADHESIVES MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 54.SURGICAL SEALANTS AND ADHESIVES MARKET FOR ORTHOPEDIC SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 55.SURGICAL SEALANTS AND ADHESIVES MARKET FOR COSMETIC SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 56.SURGICAL SEALANTS AND ADHESIVES MARKET FOR COSMETIC SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 57.SURGICAL SEALANTS AND ADHESIVES MARKET FOR OPHTHALMIC SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 58.SURGICAL SEALANTS AND ADHESIVES MARKET FOR OPHTHALMIC SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 59.SURGICAL SEALANTS AND ADHESIVES MARKET FOR UROLOGICAL SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 60.SURGICAL SEALANTS AND ADHESIVES MARKET FOR UROLOGICAL SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 61.SURGICAL SEALANTS AND ADHESIVES MARKET FOR PULMONARY SURGERIES, BY REGION, 2016–2023 ($MILLION)
TABLE 62.SURGICAL SEALANTS AND ADHESIVES MARKET FOR PULMONARY SURGERIES, BY REGION, 2016–2023 (KILOGRAM)
TABLE 63.SURGICAL SEALANTS AND ADHESIVES MARKET FOR OTHERS, BY REGION, 2016–2023 ($MILLION)
TABLE 64.SURGICAL SEALANTS AND ADHESIVES MARKET FOR OTHERS, BY REGION, 2016–2023 (KILOGRAM)
TABLE 65.GLOBAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 ($MILLION)
TABLE 66.GLOBAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 (KILOGRAM)
TABLE 67.SURGICAL SEALANTS AND ADHESIVES MARKET FOR TISSUE SEALING & HEMOSTASIS, BY REGION, 2016–2023 ($MILLION)
TABLE 68.SURGICAL SEALANTS AND ADHESIVES MARKET FOR TISSUE SEALING & HEMOSTASIS, BY REGION, 2016–2023 (KILOGRAM)
TABLE 69.SURGICAL SEALANTS AND ADHESIVES MARKET FOR TISSUE ENGINEERING, BY REGION, 2016–2023 ($MILLION)
TABLE 70.SURGICAL SEALANTS AND ADHESIVES MARKET FOR TISSUE ENGINEERING, BY REGION, 2016–2023 (KILOGRAM)
TABLE 71.SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 ($MILLION)
TABLE 72.SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION, 2016–2023 (KILOGRAM)
TABLE 73.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 74.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 75.NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 76.NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 77.NORTH AMERICA POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 78.NORTH AMERICA POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 79.NORTH AMERICA POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 80.NORTH AMERICA POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 81.NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 ($MILLION)
TABLE 82.NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 (KILOGRAM)
TABLE 83.NORTH AMERICA SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 ($MILLION)
TABLE 84.NORTH AMERICA SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 (KILOGRAM)
TABLE 85.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 ($MILLION)
TABLE 86.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 (KILOGRAM)
TABLE 87.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 ($MILLION)
TABLE 88.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 (KILOGRAM)
TABLE 89.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 90.NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 (KILOGRAM)
TABLE 91.COMPANIES OFFERING VARIOUS SURGICAL SEALANTS AND ADHESIVES IN EUROPE
TABLE 92.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 93.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 94.EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 95.EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 96.EUROPE POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 97.EUROPE POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 98.EUROPE POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 99.EUROPE POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 100.EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 ($MILLION)
TABLE 101.EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 (KILOGRAM)
TABLE 102.EUROPE SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 ($MILLION)
TABLE 103.EUROPE SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 (KILOGRAM)
TABLE 104.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 ($MILLION)
TABLE 105.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 (KILOGRAM)
TABLE 106.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 ($MILLION)
TABLE 107.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 (KILOGRAM)
TABLE 108.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 109.EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 (KILOGRAM)
TABLE 110.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 111.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 112.ASIA-PACIFIC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 113.ASIA-PACIFIC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 114.ASIA-PACIFIC POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 115.ASIA-PACIFIC POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 116.ASIA-PACIFIC POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 117.ASIA-PACIFIC POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 118.ASIA-PACIFIC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 ($MILLION)
TABLE 119.ASIA-PACIFIC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 (KILOGRAM)
TABLE 120.ASIA-PACIFIC SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 ($MILLION)
TABLE 121.ASIA-PACIFIC SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 (KILOGRAM)
TABLE 122.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 ($MILLION)
TABLE 123.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 (KILOGRAM)
TABLE 124.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 ($MILLION)
TABLE 125.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 (KILOGRAM)
TABLE 126.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 127.ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 (KILOGRAM)
TABLE 128.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 129.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 130.LAMEA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 131.LAMEA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 132.LAMEA POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 133.LAMEA POLYPEPTIDE/PROTEIN-BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 134.LAMEA POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 ($MILLION)
TABLE 135.LAMEA POLYSACCHARIDE BASED NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT, 2016–2023 (KILOGRAM)
TABLE 136.LAMEA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 ($MILLION)
TABLE 137.LAMEA NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET, BY ORIGIN, 2016–2023 (KILOGRAM)
TABLE 138.LAMEA SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 ($MILLION)
TABLE 139.LAMEA SYNTHETIC AND SEMISYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET, BY TYPE, 2016–2023 (KILOGRAM)
TABLE 140.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 ($MILLION)
TABLE 141.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION, 2016–2023 (KILOGRAM)
TABLE 142.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 ($MILLION)
TABLE 143.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION, 2016–2023 (KILOGRAM)
TABLE 144.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 ($MILLION)
TABLE 145.LAMEA SURGICAL SEALANTS AND ADHESIVES MARKET, BY COUNTRY, 2016–2023 (KILOGRAM)
TABLE 146.B. BRAUN: COMPANY SNAPSHOT
TABLE 147.B.BRAUN : OPERATING SEGMENTS
TABLE 148.B.BRAUN : PRODUCT PORTFOLIO
TABLE 149.BAXTER: COMPANY SNAPSHOT
TABLE 150.BAXTER: OPERATING SEGMENTS
TABLE 151.BAXTER: PRODUCT PORTFOLIO
TABLE 152.BD: COMPANY SNAPSHOT
TABLE 153.BD: OPERATING SEGMENTS
TABLE 154.BD: PRODUCT PORTFOLIO
TABLE 155.CRYOLIFE: COMPANY SNAPSHOT
TABLE 156.CRYOLIFE: PRODUCT CATEGORIES
TABLE 157.CRYOLIFE: PRODUCT PORTFOLIO
TABLE 158.CSL: COMPANY SNAPSHOT
TABLE 159.CSL: PRODUCT SEGMENTS
TABLE 160.CSL: PRODUCT PORTFOLIO
TABLE 161.INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 162.INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 163.INTEGRA LIFE SCIENCES: PRODUCT PORTFOLIO
TABLE 164.J & J: COMPANY SNAPSHOT
TABLE 165.J & J: OPERATING BUSINESS SEGMENT
TABLE 166.J & J: PRODUCT PORTFOLIO
TABLE 167.OCULAR THERAPEUTIX: COMPANY SNAPSHOT
TABLE 168.OCULAR THERAPEUTIX: PRODUCT PORTFOLIO
TABLE 169.SANOFI: COMPANY SNAPSHOT
TABLE 170.SANOFI: OPERATING SEGMENTS
<

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings